Documents
Documents created during the development process.
Appeal
Final appraisal determination: 2
Draft guidance
Invitation to participate
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014
-
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014
-
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014
-
Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014
-